The 2026 MM&M Agency 100 posted today. This annual ranking of the top 100 medical marketing agencies in North America is published annually by Medical Marketing & Media, the media brand of record for pharmaceutical marketing and commercialization.
The Agency 100 made its first appearance in 2021.
This year, for the first time, Bospar appears on it.
That’s a big deal for us.
Entering the Healthcare Space
Bospar built its name in B2B technology PR. We are proud of that foundation. Our tech playbook combines data-driven storytelling, aggressive earned media strategies and thought leadership development. It works for startups and enterprises and generates award-winning results for our clients.
But as our reputation in tech PR grew, prospects started arriving from a different direction: Pharma and healthcare technology companies, with platforms designed to solve problems in the clinical environment or care management.
The Clients That Propelled Our Practice
Our early healthcare work taught us two things quickly: the stakes are extraordinarily high, and the audience, whether a chief medical officer, a health system administrator or an overwhelmed family caregiver, requires communications that are both precise and genuinely human.
Consider Together by Renee. With a simple selfie, the company’s app could measure vital signs, including blood pressure, heart rate, and respiratory rate, a real “wow” factor in a category crowded with incremental innovation. Bospar connected that technology to some of the most urgent health narratives in America: an aging population, rising mental health concerns and the stubborn persistence of medication non-adherence. The result was a 3,000% increase in app downloads within a single week. Notably, the surge came largely from adults 55 and older, a group typically among the hardest to reach with a mobile health product.
Then came Carta Healthcare. The company’s AI-driven platform was entering the market at precisely the moment when generative AI was generating as much public anxiety as it was excitement. Our task was not simply to generate coverage; it was to shift the narrative, positioning AI not as a threat to healthcare providers but as a trusted partner for improving patient outcomes. The campaign delivered: 1.66 billion unique monthly visitors across earned media placements, a 3x revenue increase for the client and a 50% expansion of their healthcare ecosystem client base.
These early successes led to an ongoing partnership with a major pharmaceutical company, one that prefers not to be named publicly. More healthcare clients followed.
Our healthcare/pharma sector growing, we brought on Sarah Dray as a dedicated Content Director for Healthcare, overseeing content for client accounts in the healthcare, pharmaceutical and life sciences space. Her experience in neuroscience and public health, honed as a clinical research coordinator in the vaccine center and as a research associate in the Neuroscience Institute, combined with her commitment to health literacy, is a tremendous asset to our healthcare and pharma clients.
What the MM&M Agency 100 Represents
The MM&M Agency 100 is, in the words of the publication itself, the definitive guide to the world of medical marketing agencies. Each year’s edition is the product of a rigorous multi-month editorial process, compiling financial data, client relationships, agency profiles and industry trend analysis across more than 100 firms. The 2025 edition, which was 200-pages plus, was recognized with a Jesse H. Neal Award, widely considered the “Pulitzer of B2B journalism,” for Best Single Issue of a Tabloid/Newspaper/Magazine.
The list carries weight because of what it takes to earn a place on it. Agencies submit detailed financial data and client information. Editorial teams analyze the landscape and make judgment calls. The result is a document that pharmaceutical marketers, health system communications directors and agency search consultants use as an actual roadmap, not just a feel-good ranking.
For agencies that work in pharma and healthcare marketing, appearing on the Agency 100 signals you belong to the conversation, that the people who make agency decisions in this industry know you exist and have a basis for evaluating your capabilities. For a PR agency that built its reputation in tech and has been quietly earning its stripes in healthcare for several years, appearing on this list for the first time is public acknowledgment of what we’ve been doing.
This year’s theme asked every participating agency to design a video game to represent their company. We find that framing apt. Building a healthcare practice from the ground up, with a foundation in tech PR, is not unlike leveling up in a game that has significantly more complex rules than the last one you played. You carry your skills forward. You learn new mechanics. You fail occasionally. You adjust. And eventually, if you have done the work honestly, you reach a new tier.
What Comes Next
Appearing on the MM&M Agency 100 for the first time is not a destination. It is a marker on our journey. The healthcare and pharma industry is undergoing an extraordinary transformation: AI is entering clinical decision-making, payment integrity is being reshaped by new data capabilities, the regulatory environment is in flux and the pressure on health systems to communicate clearly with increasingly skeptical audiences has never been greater.
Bospar is positioned to help clients climb that hill. We’ve made deliberate choices to build genuine expertise, from the early health tech wins that proved our model to the neuroscientist on our content team to the confidential pharma relationships that have deepened our industry fluency, every step has been intentional.
The MM&M Agency 100 identifies who is doing serious work in healthcare marketing.
We are proud to be on it.
